4/A: Omada Health CEO Sean Duffy Files Form 4/A

Omada Health CEO Sean P. Duffy filed an amended Form 4, correcting previously omitted stock option exercise transactions and updating beneficial ownership.

Summary

• This filing is an amended Form 4 (Form 4/A) by Sean P. Duffy, CEO of Omada Health, Inc. (OMDA).
• The amendment corrects an omission in the original Form 4 filed on June 26, 2026, specifically regarding stock option exercise transactions.
• These exercises were part of same-day exercise-and-sale transactions, with the sales having been reported on time.
• The omission led to an understatement of the securities beneficially owned following the sales.
• The filing details multiple transactions of common stock acquisitions and dispositions, as well as stock option exercises, occurring between June 24, 2026, and June 26, 2026.
• A significant portion of the shares (851,659) are held indirectly in family trusts for the benefit of family members.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily serving as a correction of administrative errors in reporting insider transactions rather than indicating new strategic or financial developments.

Positives

• The filing demonstrates a commitment to accurate reporting by amending the previous filing to correct an omission.
• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-sensitive trading activity.
• All reported stock options are 100% vested and exercisable.

Negatives

• An omission in the original filing led to an understatement of beneficial ownership, requiring an amendment.
• Multiple transactions involved selling stock at prices significantly higher than the exercise price of the options, indicating realized gains.

Risks

• The filing does not explicitly mention any new risks or challenges.
• Potential future sales from the family trusts could impact share availability, though this is not a stated risk in the document.

Future Outlook

The filing itself is a historical record of transactions and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common for executives managing their personal portfolios. The correction of an omission highlights the importance of meticulous reporting in the healthcare technology sector, where transparency is key.

Related Party Transactions

• Shares are held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: The correction of ownership figures provides a more accurate picture of beneficial ownership. The transactions themselves, executed under a 10b5-1 plan, are generally viewed as less impactful than discretionary trades.
• Employees: No direct impact mentioned.
• Creditors: No direct impact mentioned.
• Suppliers/Customers: No direct impact mentioned.

Next Steps

• No specific next steps are outlined in this filing.
• The company's ongoing operations and future financial reporting will provide further insights.

Key Dates

Keywords

Omada Health, OMDA, Form 4/A, Sean P. Duffy, Stock Options, Beneficial Ownership, Insider Trading, 10b5-1 Plan, SEC Filing, Executive Transactions